Waters Corporation Stock

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-04-26 pm EDT 5-day change 1st Jan Change
311.3 USD +0.96% Intraday chart for Waters Corporation +5.13% -5.45%
Sales 2024 * 2.98B Sales 2025 * 3.16B Capitalization 18.29B
Net income 2024 * 656M Net income 2025 * 725M EV / Sales 2024 * 6.59 x
Net Debt 2024 * 1.38B Net Debt 2025 * 1.1B EV / Sales 2025 * 6.13 x
P/E ratio 2024 *
27.9 x
P/E ratio 2025 *
25 x
Employees 7,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.96%
1 week+5.13%
Current month-9.57%
1 month-7.93%
3 months-1.52%
6 months+27.35%
Current year-5.45%
More quotes
1 week
294.71
Extreme 294.71
316.06
1 month
288.94
Extreme 288.94
347.22
Current year
288.94
Extreme 288.94
363.80
1 year
231.90
Extreme 231.9
363.80
3 years
231.90
Extreme 231.9
428.22
5 years
154.39
Extreme 154.39
428.22
10 years
93.56
Extreme 93.56
428.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 20-08-31
Director of Finance/CFO 48 21-05-11
Chief Operating Officer - 21-12-31
Members of the board TitleAgeSince
Director/Board Member 63 18-08-31
Director/Board Member 67 23-03-26
Director/Board Member 70 06-04-30
More insiders
Date Price Change Volume
24-04-26 311.3 +0.96% 270,575
24-04-25 308.4 -0.61% 381,559
24-04-24 310.2 -0.97% 530,956
24-04-23 313.3 +4.70% 561,559
24-04-22 299.2 +1.06% 358,283

Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT

More quotes
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
311.3 USD
Average target price
325.4 USD
Spread / Average Target
+4.52%
Consensus